Advertisement News Archives - Page 2163 of 5230 - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

News

August 3, 2026

IMPACT Therapeutics grants Pharmanovia exclusive $488m rights to senaparib

China-based IMPACT Therapeutics and Pharmanovia have entered an exclusive licensing deal worth up to €423.5m ($488.3m), giving Pharmanovia rights to manufacture, develop, and commercialise senaparib in 66 countries.

IMPACT Therapeutics grants Pharmanovia exclusive $488m rights to senaparib